Meredith Shiels

From WikiMD's Food, Medicine & Wellness Encyclopedia

Meredith Shiels is a renowned epidemiologist and cancer researcher currently working at the National Cancer Institute (NCI). She has made significant contributions to the field of cancer epidemiology, particularly in the study of skin cancer and non-Hodgkin lymphoma.

Early Life and Education[edit | edit source]

Meredith Shiels was born and raised in United States. She completed her undergraduate studies in biology and public health before pursuing a Master's degree in epidemiology. She later earned her PhD in the same field, focusing her research on the epidemiology of cancer.

Career[edit | edit source]

Shiels began her career as a researcher at the National Cancer Institute, where she has since held various positions. Her work primarily focuses on the epidemiology of cancer, with a particular interest in skin cancer and non-Hodgkin lymphoma. She has published numerous peer-reviewed articles in prestigious medical journals, contributing significantly to our understanding of these diseases.

Research[edit | edit source]

Shiels' research has provided valuable insights into the risk factors and epidemiology of various types of cancer. She has conducted extensive studies on the impact of UV radiation and other environmental factors on the incidence of skin cancer. Her work on non-Hodgkin lymphoma has shed light on the role of immune system dysfunction in the development of this disease.

Recognition[edit | edit source]

In recognition of her contributions to the field of cancer epidemiology, Shiels has received several awards and honors. She is also a member of various professional organizations, including the American Association for Cancer Research and the American Society of Clinical Oncology.

See Also[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD